ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,328.78
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Biofrontera (B8F)

  7. Biofrontera (B8F) News

Biofrontera (B8F)

Biofrontera
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:B8F
DateTimeSourceHeadlineSymbolCompany
15/04/201607:00GlobeNewswireBiofrontera AG: Biofrontera Reports Full Year 2015 Financial ResultsLSE:B8FBiofrontera
07/04/201613:00GlobeNewswireBiofrontera AG: Notice of Annual Results 2016LSE:B8FBiofrontera
04/04/201610:57GlobeNewswireBiofrontera Announces NDA Progress Update for BF-200 ALALSE:B8FBiofrontera
18/02/201607:00UK RegulatoryAIM Cancellation - Biofrontera AGLSE:B8FBiofrontera
16/02/201616:45GlobeNewswireBiofrontera AG: Biofrontera AG resolves on capital increaseLSE:B8FBiofrontera
16/02/201614:14Alliance NewsAlliance NewsBiofrontera Raises EUR4.4 Million In Share Placing (ALLISS)LSE:B8FBiofrontera
16/02/201613:58UK RegulatoryBiofrontera AG Private PlacementLSE:B8FBiofrontera
11/02/201615:57Alliance NewsAlliance NewsBiofrontera Gets "Excellent" Results From BF-200 ALA Phase III TrialsLSE:B8FBiofrontera
11/02/201615:30GlobeNewswireBiofrontera AG: Pivotal Phase III Data Demonstrate Significant Efficacy and Excellent Safety for BF-200 ALA Treatment of Supe...LSE:B8FBiofrontera
11/02/201615:30UK RegulatoryBiofrontera AG Phase III studies updateLSE:B8FBiofrontera
28/01/201611:12Alliance NewsAlliance NewsBiofrontera Sees "Excellent" Result From Phase III Ameluz StudyLSE:B8FBiofrontera
28/01/201610:28UK RegulatoryBiofrontera AG Excellent results in Ameluz BCC clinical studyLSE:B8FBiofrontera
26/01/201610:03Alliance NewsAlliance NewsBiofrontera Says US Regulator Completes Mid-Cycle Ameluz ReviewLSE:B8FBiofrontera
26/01/201609:49UK RegulatoryBiofrontera AG FDA completes Ameluz NDA mid-cycle reviewLSE:B8FBiofrontera
20/01/201607:00UK RegulatoryBiofrontera AG Notice of Cancellation from Trading on AIMLSE:B8FBiofrontera
07/01/201608:52Alliance NewsAlliance NewsBiofrontera Welcomes European CE Marking For IndoorLux SystemLSE:B8FBiofrontera
07/01/201607:00UK RegulatoryBiofrontera AG CE Marking Granted for IndoorLux® CollaborationLSE:B8FBiofrontera
31/12/201511:57UK RegulatoryBiofrontera AG Total Voting RightsLSE:B8FBiofrontera
23/12/201514:54Alliance NewsAlliance NewsBiofrontera Granted Exemption In US From Ameluz Drug Application FeeLSE:B8FBiofrontera
23/12/201514:30UK RegulatoryBiofrontera AG FDA Grants Small Business Waiver of US$2.3mLSE:B8FBiofrontera
10/12/201507:00UK RegulatoryBiofrontera AG Issue of equity and total voting rightsLSE:B8FBiofrontera
07/12/201507:59Alliance NewsAlliance NewsBiofrontera's Ameluz Granted Marketing Approval In SwitzerlandLSE:B8FBiofrontera
07/12/201507:00UK RegulatoryBiofrontera AG Marketing approval for Ameluz® in SwitzerlandLSE:B8FBiofrontera
23/11/201515:26Alliance NewsAlliance NewsBiofrontera Disappointed By Take-up In Share Placing (ALLISS)LSE:B8FBiofrontera
23/11/201515:05UK RegulatoryBiofrontera AG Result of Open Offer and Private PlacementLSE:B8FBiofrontera
20/11/201508:14Alliance NewsAlliance NewsBiofrontera Reiterates Revenue Expectation As Nine Month Growth 31%LSE:B8FBiofrontera
20/11/201507:00UK RegulatoryBiofrontera AG 3rd Quarter ReportLSE:B8FBiofrontera
19/11/201509:10Alliance NewsAlliance NewsBiofrontera Says Clinical Phase Of Basal Cell Carcinoma Trial FinishedLSE:B8FBiofrontera
19/11/201508:00UK RegulatoryBiofrontera AG Final patient visit in Phase III trial for BCCLSE:B8FBiofrontera
12/11/201513:00UK RegulatoryBiofrontera AG Notice of Q3 ResultsLSE:B8FBiofrontera
 Showing the most relevant articles for your search:LSE:B8F

Your Recent History

LSE
GKP
Gulf Keystone Petroleum
LSE
BIRD
Blackbird
LSE
VAST
Vast Resources
LSE
BARC
Barclays
LSE
JWNG
Jaywing
LSE
SRT
Srt Marine Systems
LSE
PHE
Powerhouse Energy
LSE
PANR
Pantheon Resources
LSE
LLOY
Lloyds Banking
LSE
TAVI
Tavistock Investments
LSE
GDR
Genedrive
LSE
SHED
Urban Logistics Reit
LSE
HMI
Harvest Minerals
LSE
AAZ
Anglo Asian Mining
LSE
EKF
Ekf Diagnostics
LSE
BBSN
Brave Bison
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved